- Home
- QGEN vs MKTX Comparison
QGEN vs MKTX Comparison
Compare QGEN & MKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QGEN
- MKTX
- Stock Information
- Founded
- QGEN 1986
- MKTX 2000
- Country
- QGEN Netherlands
- MKTX United States
- Employees
- QGEN N/A
- MKTX N/A
- Industry
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- MKTX Investment Bankers/Brokers/Service
- Sector
- QGEN Health Care
- MKTX Finance
- Exchange
- QGEN Nasdaq
- MKTX Nasdaq
- Market Cap
- QGEN 9.9B
- MKTX 8.1B
- IPO Year
- QGEN 1996
- MKTX 2004
- Fundamental
- Price
- QGEN $40.04
- MKTX $210.83
- Analyst Decision
- QGEN Buy
- MKTX Hold
- Analyst Count
- QGEN 8
- MKTX 9
- Target Price
- QGEN $49.79
- MKTX $254.78
- AVG Volume (30 Days)
- QGEN 1.1M
- MKTX 581.4K
- Earning Date
- QGEN 04-28-2025
- MKTX 05-06-2025
- Dividend Yield
- QGEN 3.31%
- MKTX 1.44%
- EPS Growth
- QGEN N/A
- MKTX 6.28
- EPS
- QGEN 0.38
- MKTX 7.28
- Revenue
- QGEN $1,978,214,000.00
- MKTX $817,097,000.00
- Revenue This Year
- QGEN $5.15
- MKTX $7.65
- Revenue Next Year
- QGEN $6.49
- MKTX $10.12
- P/E Ratio
- QGEN $103.78
- MKTX $29.05
- Revenue Growth
- QGEN 0.66
- MKTX 8.58
- 52 Week Low
- QGEN $37.63
- MKTX $186.84
- 52 Week High
- QGEN $47.93
- MKTX $296.68
- Technical
- Relative Strength Index (RSI)
- QGEN 51.72
- MKTX 49.07
- Support Level
- QGEN $39.31
- MKTX $210.48
- Resistance Level
- QGEN $40.27
- MKTX $221.14
- Average True Range (ATR)
- QGEN 0.55
- MKTX 3.81
- MACD
- QGEN 0.16
- MKTX -0.19
- Stochastic Oscillator
- QGEN 82.59
- MKTX 9.24
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).
About MKTX MarketAxess Holdings Inc.
Founded in 2000, MarketAxess is a leading electronic fixed-income trading platform that connects broker/dealers and institutional investors. The company is primarily focused on credit based fixed income securities with its main trading products being US investment-grade and high-yield bonds, Eurobonds, and Emerging Market corporate debt. Recently the company has expanded more aggressively into Treasuries and municipal bonds with the acquisitions of LiquidityEdge and MuniBrokers in 2019 and 2021, respectively. The company also provides pre- and post-trade services with its acquisition of Regulatory Reporting Hub from Deutsche Börse Group in 2020 adding to its product offerings.